v3.20.1
Licensing, Acquisitions, and Other Arrangements - Proposed Acquisition of Allergan plc (Details) - USD ($)
$ / shares in Units, $ in Billions
1 Months Ended
May 31, 2020
Jun. 24, 2019
Business Acquisition    
Closing price of AbbVie's common stock   $ 78.45
Allergan plc | Scenario, forecast    
Business Acquisition    
Total consideration $ 63  
Shares of AbbVie stock received by Allergan shareholders 0.8660  
Cash per share received by Allergan shareholders $ 120.30